Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Endocrinology
•
Adrenal Disorders
Does Entresto interfere with the measurement of ARR (Aldosterone to Renin Ratio) when working up a patient for hyperaldosteronism?
Related Questions
What is your approach to differentiating pseudo-Cushing's state from Cushing's syndrome?
Can 24-hour urine aldosterone levels be used to screen for primary aldosteronism in a patient taking finerenone?
What strategies do you use to prevent overcorrection of serum sodium in patients with severe hyponatremia and adrenal insufficiency when initiating glucocorticoid therapy?
In your practice, when do you opt to treat unilateral primary hyperaldosteronism medically rather than surgically?
What factors guide you in adjusting the dose of fludrocortisone in a patient with primary adrenal insufficiency?
How do you personalize glucocorticoid dosing for patients with adrenal insufficiency during non-standard stress events, such as unexpected major life changes or unusual physical exertion?
In patients with hypertension and suspected primary aldosteronism who have undergone negative confirmatory testing, what follow-up and monitoring strategies would you recommend to ensure early detection of potential aldosteronism?
Would you expect an oral sodium loading test to be positive in secondary hyperaldosteronism or pseudohyperaldosteronism?
In what clinical scenarios should we use the 2-day 2mg DST instead of the 1mg overnight DST for screening of Cushing syndrome?
When performing adrenal vein sampling, is calculating selectivity index using androstenedione superior to using cortisol alone for determining successful catheterization?
